1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Industry in Asia Countries Market Research & Statistics

Drug Discovery and Development Industry in Asia Countries Market Research & Statistics

About 200 reports

Download Unlimited Documents from Trusted Public Sources

Drug Discovery And Development Industry in India - Forecast

  • July 2016
    5 pages
  • Drug Discovery ...  

    Clinical Trial  

  • India  

    Asia  

View report >

Drug Discovery And Development Industry in Japan

  • March 2016
    18 pages
  • Drug Discovery ...  

  • Japan  

    Asia  

    World  

View report >

Drug Discovery And Development Industry in China and Mexico - Forecast

  • June 2016
    4 pages
  • Drug Discovery ...  

  • China  

    Mexico  

View report >

Renal Disease and Diabetes Statistics in China - Forecast

  • June 2016
    3 pages
  • Renal Disease  

    Diabetes  

    Biosimilar  

  • China  

    Asia  

View report >

Clinical Trial Industry in India and the US

  • June 2016
    4 pages
  • Clinical Trial  

  • India  

    United States  

View report >

Genome Sequencing Industry in China

  • April 2016
    15 pages
  • Genome Sequenci...  

    MALDI TOF  

  • China  

View report >

Clinical Trial Industry

  • January 2016
    4 pages
  • Clinical Trial  

  • United States  

View report >

Clinical Trial Industry in Japan

  • January 2016
    26 pages
  • Clinical Trial  

  • Japan  

View report >

Pharmaceutical Market in China

  • January 2016
    2 pages
  • Pharmaceutical  

    Dementia  

    Clinical Trial  

  • China  

View report >

Therapy Market in South Korea and Japan - Forecast

  • October 2015
    13 pages
  • Therapy  

    Pharmaceutical  

    Clinical Trial  

  • South Korea  

    Japan  

View report >


62 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 750 - $ 4 995)

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • $ 4 995
  • Industry report
  • May 2016
  • by GBI Research

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Non-Small Cell Lung Cancer (NSCLC) is ...

Curetis N.v. (cure) - Product Pipeline Analysis, 2016 U ...

June 2016 $ 750

Orbusneich - Product Pipeline Analysis, 2016 Update

June 2016 $ 750

Microport Scientific Corporation (853) - Product Pipeli ...

June 2016 $ 750

Outsourcing In Drug Discovery, 7th Edition

April 2016 $ 4 200

Global Cloud Computing In Pharmaceutical Research And D ...

April 2016 $ 2 800

Clinical Trials Market In India - 2016; Market Size, Ma ...

April 2016 $ 4 000

Fibrinogen Deficiency (factor I Deficiency) - Pipeline ...

March 2016 $ 2 000

India Pharma Outlook 2016: Milestones To Watch – Grow ...

March 2016 $ 1 500

Dental Bone Graft Substitutes - Medical Devices Pipelin ...

March 2016 $ 2 500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.